Key Documents

View All Documentation

Clioquinol

Name: Clioquinol
Brand: USP
Price: 632 CAD

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

5-Chloro-7-iodo-8-quinolinol, 5-Chloro-8-hydroxy-7-iodoquinoline, Clioquinol, Iodochlorhydroxyquin

Select a Size

Change View

Pack Size	SKU	Availability	Price
500 mg		Please contact Customer Service for Availability	$632.00

About This Item

Empirical Formula (Hill Notation):

C₉H₅ClINO

CAS Number:

130-26-7

Molecular Weight:

305.50

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329749425

MDL number:

MFCD00006787

Beilstein/REAXYS Number:

153637

$632.00

Please contact Customer Service for Availability

Request a Bulk Order

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

API family

clioquinol

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Oc1c(I)cc(Cl)c2cccnc12

InChI

1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H

InChI key

QCDFBFJGMNKBDO-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Clioquinol USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Clioquinol and Hydrocortisone Cream
Clioquinol and Hydrocortisone Ointment
Clioquinol Cream
Clioquinol Ointment
Compound Clioquinol Topical Powder

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item	Y0000364	BP084	33931
USP 1138201 Clioquinol	Y0000364 Clioquinol	BP084 Clioquinol	Supelco 33931 Clioquinol
manufacturer/tradename USP	manufacturer/tradename EDQM	manufacturer/tradename BP	manufacturer/tradename -
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade analytical standard
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) forensics and toxicology pharmaceutical (small molecule)
format neat	format neat	format neat	format neat
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C
API family clioquinol	API family clioquinol	API family clioquinol	API family -

Still not finding the right product?

Explore all of our products under Clioquinol

pictograms

GHS06

signalword

Danger

hcodes

H301,H315,H317,H319

pcodes

P261 - P264 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Superoxide dismutase as a target of clioquinol-induced neurotoxicity.

Kazuyuki Kawamura et al.

Biochemical and biophysical research communications, 452(1), 181-185 (2014-04-24)

Subacute myelo-optico-neuropathy (SMON) is a progressive neurological disorder affecting the spinal cord, peripheral nerves and optic nerves. Although it has been assumed that SMON was caused by intoxication of clioquinol, the mechanism underlying clioquinol-induced neurotoxicity is not fully understood. This

A newly designed molecule J2326 for Alzheimer's disease disaggregates amyloid fibrils and induces neurite outgrowth.

Pei-Teh Chang et al.

Neuropharmacology, 92, 146-157 (2015-01-18)

Alzheimer's disease is a neurodegenerative disorder characterized by deposition of β-amyloid (Aβ) fibrils accompanied with progressive neurite loss. None of the clinically approved anti-Alzheimer's agents target both pathological processes. We hypothesized that conjugation of a metal chelator to destabilize Aβ

Antienflamatuar and antiadhesive effect of clioquinol.

Turan Yildiz et al.

International journal of surgery (London, England), 15, 17-22 (2015-02-02)

The aim of this study is to investigate the expected adhesion-modifying effect of clinoquinol which has metal-chelating feature that limits the inflammation and fibroblastic activity. A total of 40 Wistar Albino rats were included, which were divided into 5 groups.

Global Trade Item Number

SKU	GTIN
1138201-500MG	04061838701473

Questions

Reviews

No rating value